Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have had surgery to remove a liver cancer (hepatocellular carcinoma, or HCC)
- People for whom next-generation sequencing (a type of detailed genetic testing) data is available from their cancer tissue
- People for whom preserved tissue samples (stored in a wax-like material called paraffin) are available for laboratory testing
Who may not be able to join:
- There are no stated exclusion criteria for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Vasuri, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: 0512143761
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
associations between p53 and beta-Catenin and the presence of the genetic mutations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.